1990
DOI: 10.3109/00365529009091927
|View full text |Cite
|
Sign up to set email alerts
|

Prostaglandins and Peptic Ulcer Therapy

Abstract: Walt RP. Prostaglandins and peptic ulcer therapy. Scand J Gastroenterol IYW, The expectation that prostaglandin analogues would improve the ulcer healing abilities of other agents by combining mucosal protection with decreased acid secretion has been proved unwarranted. The ulcer healing capabilities of these drugs reflect their antisecretory potency. A role for these drugs in ulcer healing is questionable but their use has been advocated most strongly to prevent ulceration developing during treatment with non… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
1

Year Published

1992
1992
2000
2000

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(4 citation statements)
references
References 47 publications
0
3
1
Order By: Relevance
“…Adults with peptic ulcer disease, especially during treatment with nonsteroidal antiinflammatory drugs, can be treated with dPGE2 (Arbocet; Upjohn, Kalamazoo, MI) (13,29). However, our present data suggest that there may be an age-related delay in the protective effects of dPGE2.…”
Section: Discussioncontrasting
confidence: 54%
“…Adults with peptic ulcer disease, especially during treatment with nonsteroidal antiinflammatory drugs, can be treated with dPGE2 (Arbocet; Upjohn, Kalamazoo, MI) (13,29). However, our present data suggest that there may be an age-related delay in the protective effects of dPGE2.…”
Section: Discussioncontrasting
confidence: 54%
“…Two analogues, misoprostol and enprostil, are currently being marketed for peptic ulcer disease and are the most widely used (Walt 1990). Enprostil is a synthetic prostaglandin E2 analogue with similar properties to misoprostol (Aly 1987).…”
Section: Prostaglandin Analoguesmentioning
confidence: 98%
“…Divalent cations have been shown to prevent mucosal injury, although the mechanisms responsible are still controversial (Szabo et a1 1981;Esplugues et a1 1985;Dupuy & Szabo 1986). As shown in Table 4, pretreatment with indomethacin prevents the defensive effects of almagate, thus suggesting that the protective effects of the compound are related to an increase in endogenous gastroprotective prostaglandins (Whittle & Esplugues 1989;Walt 1990;Whittle 1993).…”
Section: I1mentioning
confidence: 99%